Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Wj Huizinga

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Lupus Science & Medicine|January 8, 2022
To treat or not to treat with immunosuppressive therapy: psychiatric disorders in patients with systemic lupus erythematosusRory C Monahan, Anne M E Blonk, Tom Wj Huizinga, et al.
Journal of Scleroderma and Related Disorders|November 4, 2024
Troponin I levels in systemic sclerosis patients with myocardial involvementEva M Hoekstra, Sophie Ie Liem, Saad Ahmed, et al.
Annals of the Rheumatic Diseases|November 18, 2023
Long-term mortality in treated-to-target RA and UA: results of the BeSt and IMPROVED cohortSascha Louise Heckert, Johanna Maria Maassen, S le Cessie, et al.
Annals of the Rheumatic Diseases|December 16, 2022
Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritisLotte van Ouwerkerk, Maarten Boers, Paul Emery, et al.
RMD Open|July 28, 2023
Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosisCorrie M Wortel, Sophie Ie Liem, Nina M van Leeuwen, et al.
Journal of Scleroderma and Related Disorders|September 25, 2023
The long-term course of the Health Assessment Questionnaire in patients with systemic sclerosisSophie Ie Liem, Sytske Anne Bergstra, Jacopo Ciaffi, et al.
Annals of the Rheumatic Diseases|July 28, 2017
The extensive glycosylation of the ACPA variable domain observed for ACPA-IgG is absent from ACPA-IgMAyla C Kempers, Lise Hafkenscheid, Annemarie L Dorjée, et al.
Annals of the Rheumatic Diseases|August 22, 2023
Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?Lotte van Ouwerkerk, Patrick Verschueren, Maarten Boers, et al.
Lupus|March 29, 2021
Fatigue in patients with systemic lupus erythematosus and neuropsychiatric symptoms is associated with anxiety and depression rather than inflammatory disease activityRory C Monahan, Liesbeth Jj Beaart-van de Voorde, Jeroen Eikenboom, et al.
Annals of the Rheumatic Diseases|April 26, 2022
Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritisLotte van Ouwerkerk, Andriko Palmowski, Isabell S Nevins, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Lupus Science & Medicine|January 8, 2022
To treat or not to treat with immunosuppressive therapy: psychiatric disorders in patients with systemic lupus erythematosusRory C Monahan, Anne M E Blonk, Tom Wj Huizinga, et al.
Journal of Scleroderma and Related Disorders|November 4, 2024
Troponin I levels in systemic sclerosis patients with myocardial involvementEva M Hoekstra, Sophie Ie Liem, Saad Ahmed, et al.
Annals of the Rheumatic Diseases|November 18, 2023
Long-term mortality in treated-to-target RA and UA: results of the BeSt and IMPROVED cohortSascha Louise Heckert, Johanna Maria Maassen, S le Cessie, et al.
Annals of the Rheumatic Diseases|December 16, 2022
Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritisLotte van Ouwerkerk, Maarten Boers, Paul Emery, et al.
RMD Open|July 28, 2023
Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosisCorrie M Wortel, Sophie Ie Liem, Nina M van Leeuwen, et al.
Journal of Scleroderma and Related Disorders|September 25, 2023
The long-term course of the Health Assessment Questionnaire in patients with systemic sclerosisSophie Ie Liem, Sytske Anne Bergstra, Jacopo Ciaffi, et al.
Annals of the Rheumatic Diseases|July 28, 2017
The extensive glycosylation of the ACPA variable domain observed for ACPA-IgG is absent from ACPA-IgMAyla C Kempers, Lise Hafkenscheid, Annemarie L Dorjée, et al.
Annals of the Rheumatic Diseases|August 22, 2023
Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?Lotte van Ouwerkerk, Patrick Verschueren, Maarten Boers, et al.
Lupus|March 29, 2021
Fatigue in patients with systemic lupus erythematosus and neuropsychiatric symptoms is associated with anxiety and depression rather than inflammatory disease activityRory C Monahan, Liesbeth Jj Beaart-van de Voorde, Jeroen Eikenboom, et al.
Annals of the Rheumatic Diseases|April 26, 2022
Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritisLotte van Ouwerkerk, Andriko Palmowski, Isabell S Nevins, et al.
Pageof 5